SCHEMBL30108833

SCHEMBL30108833

COc1cc(C)ccc1-c1nnc(Cl)c2cc(Br)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.36
PDE5A O76074 3/20 0.35
CRHR1 P34998 1/20 0.35
THRB P10828 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
ALOX12 P18054 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MAPT P10636 2/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28934326 1.00 ACHE (0.36) ACHEPDE5ACRHR1THRBL3MBTL1
SCHEMBL30108691 0.95 THRB (0.34) ACHEPDE5ACRHR1THRBL3MBTL1
SCHEMBL28934436 0.91 ACHE (0.41) ACHEPDE5ACRHR1THRBL3MBTL1
SCHEMBL28934496 0.87 PDE5A (0.46) ACHEPDE5ACRHR1L3MBTL1ALDH1A1
SCHEMBL28934716 0.86 ACHE (0.37) ACHECRHR1L3MBTL1LMNASMN1; SMN2
SCHEMBL28934710 0.85 ACHE (0.41) ACHEPDE5ACRHR1THRBL3MBTL1
SCHEMBL28934449 0.85 KDM4E (0.40) ACHEPDE5ACRHR1L3MBTL1LMNA
SCHEMBL28934464 0.84 MAPT (0.40) ACHECRHR1L3MBTL1LMNASMN1; SMN2
SCHEMBL25257750 0.84 AMY1A (0.39) THRBLMNAALDH1A1MEN1KMT2A
SCHEMBL30108829 0.83 THRB (0.38) CRHR1THRBSMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433163-A NLRP3 inflammasome inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2022-12-06 CN disclosed